TuHURA Biosciences, Inc.
HURA
$3.48
$0.5719.59%
| 09/30/2024 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 783.50K | 1.10M | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.73M | 4.56M | |||
| Operating Income | -3.73M | -4.56M | |||
| Income Before Tax | -5.58M | -4.54M | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.58M | -4.54M | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.58M | -4.54M | |||
| EBIT | -3.73M | -4.56M | |||
| EBITDA | -3.70M | -4.51M | |||
| EPS Basic | -0.09 | -- | |||
| Normalized Basic EPS | -0.05 | -- | |||
| EPS Diluted | -0.09 | -- | |||
| Normalized Diluted EPS | -0.05 | -- | |||
| Average Basic Shares Outstanding | 76.37M | -- | |||
| Average Diluted Shares Outstanding | 76.37M | -- | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
